MedPath

Motivational Interview and Nomophobia

Not Applicable
Completed
Conditions
Nomophobia
Smartphone Addiction
Registration Number
NCT06656013
Lead Sponsor
Sultan Ayaz Alkaya
Brief Summary

A preparation session and a motivational interview consisting of 4 sessions will be applied to nursing students. Data collection tools will be applied before, after and at 3 months.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • being over 18 years of age
  • being a first-year nursing student
  • agreeing to participate in the research
Exclusion Criteria
  • having problems understanding and speaking Turkish
  • having visual or hearing impairment
  • having a neuropsychiatric disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Nomophobia ScaleFollow-up (18 weeks after pre-test)

The scale, developed by Yıldırım and Correira (2015) and adapted to Turkish by Yıldırım et al. (2016), is itemized according to the 7-point Likert type. The scale consists of 20 items and is graded as 1 = strongly disagree, 7 = strongly agree. The total score of the scale is between 20-140. A score range of 0-20 indicates that the individual does not have nomophobia, a score range of 21-60 indicates that the individual has a low level of nomophobia, a score range of 61-100 indicates that the individual has a moderate level of nomophobia, and a score range of 101-140 indicates that the individual has a high level of nomophobia.

Smartphone Addiction Scale-Short FormFollow-up (18 weeks after pre-test)

The Turkish validity and reliability study was conducted by Noyan et al. (2015). The scale consisting of 10 questions is evaluated with a 6-point Likert scale. Scale items are graded as "(1) Strongly disagree, (2) Disagree, (3) Partially disagree, (4) Partially agree, (5) Agree, (6) Strongly agree." The total score of the scale varies between 10 and 60, and scores above 32 indicate smartphone addiction.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Gazi University

🇹🇷

Ankara, Turkey

Gazi University
🇹🇷Ankara, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.